Crossmark

Clinical consequences of a genetic predisposition toward higher benign prostate-specific antigen levels

Crossref DOI link: https://doi.org/10.1016/j.ebiom.2023.104838

Published Print: 2023-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Shi, Mingjian https://orcid.org/0000-0003-1569-9822
Shelley, John P. https://orcid.org/0000-0002-8612-3022
Schaffer, Kerry R.

Tosoian, Jeffrey J.

Bagheri, Minoo

Witte, John S.

Kachuri, Linda

Mosley, Jonathan D. https://orcid.org/0000-0001-6421-2887
Funding

Funding for this research was provided by:

Vanderbilt-Ingram Cancer Center

National Institutes of Health (K01HL165020)

National Institutes of Health (P30CA068485)

National Institutes of Health (R01CA241410)

National Institutes of Health (R01GM130791)

National Institutes of Health (T32GM007347)

National Institutes of Health (U01HG011181)

National Cancer Institute (P50GM115305)

National Cancer Institute (R01HD074711)

National Cancer Institute (R01NS032830)

National Cancer Institute (RC2GM092618)

National Cancer Institute (S10RR025141)

National Cancer Institute (U01HG004798)

National Cancer Institute (U01HG006378)

National Cancer Institute (U19HL065962)

National Cancer Institute (U2C-CA271854)

National Cancer Institute (UL1RR024975)

National Cancer Institute (UL1TR000445)

National Cancer Institute (UL1TR002243)

Prostate Cancer Foundation (20YOUN11)
License Information

Text and Data Mining valid from 2023-11-01

Text and Data Mining valid from 2023-11-01

Version of Record valid from 2023-10-05
More Information

This article is maintained by: Elsevier

Article Title: Clinical consequences of a genetic predisposition toward higher benign prostate-specific antigen levels

Journal Title: eBioMedicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ebiom.2023.104838

Content Type: article

Copyright: © 2023 The Author(s). Published by Elsevier B.V.

Document is current

Any future updates will be listed below